Fractyl Health is a biotech company based in Lexington, MA, dedicated to developing transformative therapies for metabolic diseases such as type 2 diabetes (T2D) and obesity. Their mission is to target the root causes of these conditions and deliver innovative therapies to patients as quickly and widely as possible.
With a focus on pioneering breakthrough treatments, Fractyl Health is known for their outpatient procedural therapy called Revita, which aims to modify duodenal dysfunction and restore metabolic health. They are also developing Rejuva, a novel gene therapy platform designed to improve islet function and potentially enable long-term remission of T2D and obesity. Through their innovative approach, Fractyl Health is at the forefront of advancing GLP-1 medicines and revolutionizing the treatment of metabolic diseases.
Generated from the website